Three years of research at the Yale School of Medicine have uncovered a drug that increases the potency of chemotherapy treatment 100-fold in clinical trials. The drug, Phenoxodiol, is developed by Marshall Edwards, Inc., a subsidiary of the Australian biotechnology company Novogen. According to Novogen, when Phenoxodiol was used with the anti-cancer drug docetaxel on
»